The global cholestatic pruritus therapeutics market is experiencing robust growth, driven by increasing prevalence of hepatic disorders. A significant rise in the number of patients affected by cholestatic pruritus is stimulating demand for effective treatment options. The market is defined by a varied range of therapeutic approaches, including pha